Dataset from A Phase III Safety Study of Pro-NETU in Patients Receiving Highly Emetogenic Chemotherapy (Doxorubicin/Epirubicin and Cyclophosphamide): CONSOLE-BC
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00008730
下载链接
链接失效反馈官方服务：
资源简介：
This is a multicenter, randomized, double-blind, phase 3 study to examine the safety of single intravenously administration of Pro-NETU in combination with palonosetron and dexamethasone in patients receiving doxorubicin/cyclophosphamide (AC) or epirubicin/cyclophosphamide (EC) based HEC.
For more information, visit:
https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.34088
创建时间：
2024-11-26
